Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mannkind Corp
(NQ:
MNKD
)
4.590
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mannkind Corp
< Previous
1
2
3
4
5
6
Next >
A Preview Of MannKind's Earnings
November 06, 2023
Via
Benzinga
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
November 06, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
October 31, 2023
From
MannKind
Via
GlobeNewswire
MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
October 30, 2023
From
MannKind
Via
GlobeNewswire
Why MannKind Stock Soared 19% Higher on Tuesday
August 08, 2023
The biotech delivered quite an impressive earnings report.
Via
The Motley Fool
MannKind (MNKD) Q2 2023 Earnings Call Transcript
August 08, 2023
MNKD earnings call for the period ending June 30, 2023.
Via
The Motley Fool
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback'
October 10, 2023
Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
Earnings Preview For MannKind
August 04, 2023
Via
Benzinga
Why Shares of MannKind Are Up Wednesday
May 10, 2023
The company released its first-quarter earnings report on Tuesday.
Via
The Motley Fool
MannKind (MNKD) Q1 2023 Earnings Call Transcript
May 09, 2023
MNKD earnings call for the period ending March 31, 2023.
Via
The Motley Fool
MannKind Corporation Announces Participation at Upcoming Conferences
September 05, 2023
From
MannKind
Via
GlobeNewswire
3 Biotech Stocks to Sell in August Before They Crash and Burn
August 14, 2023
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.
Via
InvestorPlace
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday
August 14, 2023
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst Justin Patterson maintained an Overweight rating. Bumble shares rose 0.9% to $16.65 in pre-market...
Via
Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
August 08, 2023
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...
Via
Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 08, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...
Via
Benzinga
MannKind Corporation Reports 2023 Second Quarter Financial Results
August 07, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference
August 01, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023
July 31, 2023
From
MannKind
Via
GlobeNewswire
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
July 13, 2023
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.
Via
InvestorPlace
7 Biotech Stocks to Sell in July
July 13, 2023
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Via
InvestorPlace
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)
June 22, 2023
From
MannKind
Via
GlobeNewswire
7 Overvalued Penny Stocks to Sell Before June 2023
May 28, 2023
It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable.
Via
InvestorPlace
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer
May 24, 2023
From
MannKind
Via
GlobeNewswire
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.
Via
InvestorPlace
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
May 10, 2023
From
MannKind
Via
GlobeNewswire
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results
May 09, 2023
Conference Call to Begin Today at 5:00 p.m. (ET)
From
MannKind
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.